Dr Reddy's Laboratories Price to Free Cash Flow Ratio 2010-2024 | RDY

Dr Reddy's Laboratories current price to free cash flow ratio as of September 21, 2024 is 41.8.

  • Dr Reddy's Laboratories average price to free cash flow ratio for 2023 was 17.82, a 41.07% increase from 2022.
  • Dr Reddy's Laboratories average price to free cash flow ratio for 2022 was 30.24, a 60.99% decline from 2021.
  • Dr Reddy's Laboratories average price to free cash flow ratio for 2021 was 77.51, a 132.48% decline from 2020.

Price to free cash flow ratio can be defined as

Dr Reddy's Laboratories Price to Free Cash Flow Ratio 2010-2024 | RDY

  • Dr Reddy's Laboratories average price to free cash flow ratio for 2023 was 17.82, a 41.07% increase from 2022.
  • Dr Reddy's Laboratories average price to free cash flow ratio for 2022 was 30.24, a 60.99% decline from 2021.
  • Dr Reddy's Laboratories average price to free cash flow ratio for 2021 was 77.51, a 132.48% decline from 2020.

Price to free cash flow ratio can be defined as

Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$20.1B
BridgeBio Pharma (BBIO)$5B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.4B
Supernus Pharmaceuticals (SUPN)$1.8B
Taysha Gene Therapies (TSHA)$449M
Personalis (PSNL)$315M
Assembly Biosciences (ASMB)$117M
Acasti Pharma (ACST)$28M
Sol-Gel Technologies (SLGL)$20M
Evoke Pharma (EVOK)$4M
Teligent (TLGT)$0M